Stocks and Investing
Stocks and Investing
Mon, April 1, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Emily Bodnar Reiterated (SLRN) at Strong Buy and Held Target at $28 on, Apr 1st, 2024
Emily Bodnar of HC Wainwright & Co., Reiterated "Acelyrin, Inc." (SLRN) at Strong Buy and Held Target at $28 on, Apr 1st, 2024.
Emily has made no other calls on SLRN in the last 4 months.
There are 2 other peers that have a rating on SLRN. Out of the 2 peers that are also analyzing SLRN, all agree with Emily's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Derek Archila of "Wells Fargo" Maintained at Hold with Increased Target to $13 on, Thursday, March 21st, 2024
- Samantha Semenkow of "Citigroup" Initiated at Hold and Held Target at $8 on, Friday, December 8th, 2023
Contributing Sources